Alteration in contractile G-protein coupled receptor expression by moist snus and nicotine in rat cerebral arteries

Toxicology and Applied Pharmacology

Volumn 252, Issue 2, 2011, Pages 138-149

  Sandhu, Hardip ^a   Xu, Cang Bao ^a,b   Edvinsson, Lars ^a,b  

^a Glostrup Research Institute   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebral arteries; Endothelin ETB receptor; Moist tobacco snus (snuff); Nicotine; Serotonin 5 HT1B receptor; Thromboxane A2 TP receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 CARBAMOYLTRYPTAMINE; CIGARETTE SMOKE; ENDOTHELIN B RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; SARAFOTOXIN S6C; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; THROMBOXANE A2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DRUG DOSE COMPARISON; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SMOKELESS TOBACCO;

ANIMALS; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMIDITY; MALE; NICOTINE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; TOBACCO, SMOKELESS; VASOCONSTRICTION;

NICOTIANA TABACUM; RATTUS;

EID: 79953700255     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.01.016     Document Type: Article

References (28)

1. Andersson G., Bjornberg G., Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J. Oral Pathol. Med. 1994, 23:161-167.
2. Ansar S., Vikman P., Nielsen M., Edvinsson L. Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3750-H3758.
3. Benowitz N.L., Jacob P., Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 1994, 268:296-303.
4. Bolinder G.M., Ahlborg B.O., Lindell J.H. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J. Intern. Med. 1992, 232:327-334.
5. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994, 46:205-229.
6. Foulds J., Ramstrom L., Burke M., Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob. Control 2003, 12:349-359.
7. Geoffroy J., Benzoni D., Sassard J. Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strain. J. Hypertens. Suppl. 1989, 7:S272-S273.
8. Haglund B., Eliasson M., Stenbeck M., Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand. J. Public Health 2007, 35:618-622.
9. Hansen-Schwartz J., Hoel N.L., Xu C.B., Svendgaard N.A., Edvinsson L. Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats. J. Neurosurg. 2003, 99:115-120.
10. Hansen-Schwartz J., Hoel N.L., Zhou M., Xu C.B., Svendgaard N.A., Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003, 52:1188-1194.
11. Hansen-Schwartz J., Svensson C.L., Xu C.B., Edvinsson L. Protein kinase mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery. Br. J. Pharmacol. 2002, 137:118-126.
12. Henriksson M., Stenman E., Edvinsson L. Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 2003, 34:1479-1483.
13. Hergens M.P., Alfredsson L., Bolinder G., Lambe M., Pershagen G., Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J. Intern. Med. 2007, 262:351-359.
14. Hergens M.P., Lambe M., Pershagen G., Ye W. Risk of hypertension amongst Swedish male snuff users: a prospective study. J. Intern. Med. 2008, 264:187-194.
15. Hoel N.L., Hansen-Schwartz J., Edvinsson L. Selective up-regulation of 5-HT(1B/1D) receptors during organ culture of cerebral arteries. NeuroReport 2001, 12:1605-1608.
16. Hogestatt E.D., Andersson K.E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand. 1983, 117:49-61.
17. Huang J.S., Ramamurthy S.K., Lin X., Le Breton G.C. Cell signalling through thromboxane A2 receptors. Cell. Signal. 2004, 16:521-533.
18. Katugampola S.D., Davenport A.P. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br. J. Pharmacol. 2001, 134:1385-1392.
19. Masaki T., Vane J.R., Vanhoutte P.M. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 1994, 46:137-142.
20. Morinelli T.A., Zhang L.M., Newman W.H., Meier K.E. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J. Biol. Chem. 1994, 269:5693-5698.
21. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41:19-26.
22. Nilsson T., Longmore J., Shaw D., Olesen I.J., Edvinsson L. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br. J. Pharmacol. 1999, 128:1133-1140.
23. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
24. Sandhu H.K., Ansar S., Edvinsson L. Comparison of MEK/ERK pathway inhibitors on the upregulation of vascular G protein coupled receptors in rat cerebral arteries. Eur. J. Pharmacol. 2010, 644:128-137.
25. Sandhu H.K., Xu C.B., Edvinsson L. Upregulation of contractile endothelin type B2 receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via activation of MAPK. Toxicol. Appl. Pharmacol. 2010, 249:25-32.
26. US Department of Health and Human Services (1986). The health consequences of using smokeless tobacco. A report of the advisory committee to the Surgeon General. Bethesda, Maryland: Public Health Service, National Institutes of Health (NIH publication No 86-2874).
27. Yun D.H., Song H.Y., Lee M.J., Kim M.R., Kim M.Y., Lee J.S., Kim J.H. Thromboxane A(2) modulates migration, proliferation, and differentiation of adipose tissue-derived mesenchymal stem cells. Exp. Mol. Med. 2009, 41:17-24.
28. Zhang J.Y., Cao L., Zheng X.H., Xu C.B., Cao Y.X. Dimethylsulfoxide-soluble smoking particles and nicotine affect vascular contractibility. Arch. Pharm. Res. 2009, 32:1475-1481.